Levodropropizine is a new substance with strong antitussive activity (symptomatic treatment of cough), mainly at the level of the trachea and bronchi, associated with antiallergic and antibronchospastic activity (prevents bronchial spasms). In addition, in animals, it has a local anesthetic effect. Levodropropizine does not cause drowsiness or physical or psychological dependence. Therapeutic doses do not affect the central nervous system. Levodropropizine does not weaken respiratory capacity or mucociliary clearance (improvement of mucus flow and transport). Levotuss is indicated for the symptomatic treatment of cough. Sale reserved for individuals over 16 years of age. Non-prescription medicine. Read the information leaflet carefully and if in doubt or if symptoms persist, consult your doctor or pharmacist. See here the eligible counties for delivery and respective MNSRM Sales Locations.
Comment